PRESS RELEASE published on 04/15/2025 at 22:00, 7 months 20 days ago Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2024 et de son Rapport Annuel 2024 (« Form 20-F ») Inventiva dépose son Document d’Enregistrement Universel 2024 et son Rapport Annuel 2024 (Form 20-F) auprès de l’AMF et de la SEC. Les documents sont disponibles sur les sites internet respectifs AMF SEC Inventiva Rapport Annuel 2024 Document D'Enregistrement Universel 2024
BRIEF published on 03/26/2025 at 21:05, 8 months 10 days ago Inventiva dévoile ses résultats financiers 2024 et ses projets stratégiques Réorganisation Stratégique Résultats Financiers 2024 Recherche & Développement Lanifibranor Financement Structuré
BRIEF published on 03/26/2025 at 21:05, 8 months 10 days ago Inventiva unveils its 2024 financial results and strategic projects Strategic Reorganization 2024 Financial Results Research & Development Lanifibranor Structured Financing
PRESS RELEASE published on 03/26/2025 at 21:00, 8 months 10 days ago Inventiva publie ses résultats financiers annuels 2024 et fait le point sur son activité Inventiva publie ses résultats financiers annuels 2024 et fait le point sur son activité avec chiffre d'affaires de 9,2 millions d'euros, trésorerie à 96,6 millions d'euros et levée de 116 millions d'euros Chiffre D'affaires Résultats Financiers Financement Trésorerie Inventiva
PRESS RELEASE published on 03/26/2025 at 21:00, 8 months 10 days ago Inventiva reports its 2024 full year results and provides a business update Inventiva reports its 2024 full year financial results with revenues of €9.2 million, cash equivalents of €96.6 million and a structured financing of up to €348 million. Significant progress in the NATiV3 Phase 3 trial of lanifibranor for MASH. Pipeline prioritization plan presented Revenues Financial Results Inventiva Cash Equivalents NATiV3 Phase 3 Trial
BRIEF published on 03/19/2025 at 21:05, 8 months 17 days ago Inventiva Announces 2024 Full-Year Financial Results Schedule Financial Results Webcast Inventiva Lanifibranor MASH Treatment
BRIEF published on 03/19/2025 at 21:05, 8 months 17 days ago Inventiva annonce le calendrier des résultats financiers annuels 2024 Résultats Financiers Webcast Inventiva Lanifibranor Traitement MASH
PRESS RELEASE published on 03/19/2025 at 21:00, 8 months 17 days ago Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results Inventiva schedules 2024 Full-Year Financial Results presentation on March 27, 2025. Webcast available. Company focused on small molecule therapies for MASH Presentation 2024 Financial Results Inventiva MASH Small Molecule Therapies
PRESS RELEASE published on 03/19/2025 at 21:00, 8 months 17 days ago Inventiva annonce la date de publication et de présentation de ses résultats financiers 2024 Inventiva annonce la date de publication et de présentation de ses résultats financiers 2024. La présentation aura lieu le 27 mars 2025 avec une conférence téléphonique le 30 mars 2025 Presentation Conférence Téléphonique Thérapies Orales Résultats Financiers 2024 Inventiva
BRIEF published on 02/26/2025 at 22:05, 9 months 7 days ago Inventiva's Lanifibranor Shows Promise in Portal Hypertension Study Preclinical Study Inventiva Liver Disease Lanifibranor Portal Hypertension
Published on 12/06/2025 at 02:00, 1 hour 30 minutes ago Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 2 hours 15 minutes ago Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 3 hours 5 minutes ago GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 3 hours 30 minutes ago Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 4 hours ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:15, 5 hours 14 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 5 hours 18 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 8 hours 32 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 9 hours 15 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 4 hours 30 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 4 hours 30 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 4 hours 30 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 4 hours 30 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 10 hours 12 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible